Pfizer Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

2,193.17

2,424.76

2,610.99

2,238.55

2,151.65

Operating profit

635.30

808.86

835.73

712.12

572.56

Interest

15.41

13.39

10.49

15.11

10.85

Gross profit

800.40

896.52

887.89

778.13

745.73

EPS (Rs)

120.51

136.38

133.89

108.77

111.29

Other income

180.51

101.05

62.65

81.12

184.02

Stock adjustment

-11.82

56.48

-72.90

14.35

-36.62

Raw material

335.80

345.27

354.29

334.74

345.21

Power and fuel

-

-

-

-

-

Employee expenses

347.80

331.68

403.67

361.06

364.51

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

886.09

882.47

1,090.20

816.28

905.99

Provisions made

-

-

-

-

-

Depreciation

62.28

105.51

115.00

109.41

103.24

Taxation

194.74

200.08

160.33

171.11

133.36

Net profit / loss

551.33

623.93

612.56

497.61

509.13

Extra ordinary item

7.95

33.00

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

45.75

45.75

45.75

45.75

45.75

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

28.97

33.36

32.01

31.81

26.61

GPM (%)

33.72

35.49

33.21

33.54

31.93

NPM (%)

23.23

24.70

22.91

21.45

21.80